The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Circulating Biomarker-Global Market Insights and Sales Trends 2025
Synopsis
The global Circulating Biomarker market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Circulating Biomarker in various end use industries. The expanding demands from the Hospital, Medical Research Center and Others,, are propelling Circulating Biomarker market. Circulating DNA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Circulating Tumor Cells segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Circulating Biomarker market, driven by demand from China, the second largest economy with some signs of stabilising, the Circulating Biomarker market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Circulating Biomarker, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Circulating Biomarker market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Circulating Biomarker market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Circulating Biomarker sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Circulating Biomarker covered in this report include Abbott Laboratories, Becton, Dickinson and Company, GE Healthcare, Epigenomics AG, Agilent Technologies, Biocept, Affymetrix and Fluxion Biosciences, etc.
The global Circulating Biomarker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Affymetrix
Fluxion Biosciences
Global Circulating Biomarker market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Circulating Biomarker market, Segment by Type:
Circulating DNA
Circulating Tumor Cells
Other
Global Circulating Biomarker market, by Application
Hospital
Medical Research Center
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Circulating Biomarker manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Circulating Biomarker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Circulating Biomarker market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Circulating Biomarker in various end use industries. The expanding demands from the Hospital, Medical Research Center and Others,, are propelling Circulating Biomarker market. Circulating DNA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Circulating Tumor Cells segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Circulating Biomarker market, driven by demand from China, the second largest economy with some signs of stabilising, the Circulating Biomarker market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Circulating Biomarker, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Circulating Biomarker market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Circulating Biomarker market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Circulating Biomarker sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Circulating Biomarker covered in this report include Abbott Laboratories, Becton, Dickinson and Company, GE Healthcare, Epigenomics AG, Agilent Technologies, Biocept, Affymetrix and Fluxion Biosciences, etc.
The global Circulating Biomarker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Affymetrix
Fluxion Biosciences
Global Circulating Biomarker market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Circulating Biomarker market, Segment by Type:
Circulating DNA
Circulating Tumor Cells
Other
Global Circulating Biomarker market, by Application
Hospital
Medical Research Center
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Circulating Biomarker manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Circulating Biomarker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Circulating Biomarker Market Overview
1.1 Circulating Biomarker Product Overview
1.2 Circulating Biomarker Market Segment by Type
1.2.1 Circulating DNA
1.2.2 Circulating Tumor Cells
1.2.3 Other
1.3 Global Circulating Biomarker Market Size by Type
1.3.1 Global Circulating Biomarker Market Size Overview by Type (2018-2029)
1.3.2 Global Circulating Biomarker Historic Market Size Review by Type (2018-2023)
1.3.3 Global Circulating Biomarker Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Circulating Biomarker Sales Breakdown by Type (2018-2023)
1.4.2 Europe Circulating Biomarker Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Circulating Biomarker Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Circulating Biomarker Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Circulating Biomarker Sales Breakdown by Type (2018-2023)
2 Global Circulating Biomarker Market Competition by Company
2.1 Global Top Players by Circulating Biomarker Sales (2018-2023)
2.2 Global Top Players by Circulating Biomarker Revenue (2018-2023)
2.3 Global Top Players by Circulating Biomarker Price (2018-2023)
2.4 Global Top Manufacturers Circulating Biomarker Manufacturing Base Distribution, Sales Area, Product Type
2.5 Circulating Biomarker Market Competitive Situation and Trends
2.5.1 Circulating Biomarker Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Circulating Biomarker Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Circulating Biomarker as of 2022)
2.7 Date of Key Manufacturers Enter into Circulating Biomarker Market
2.8 Key Manufacturers Circulating Biomarker Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Circulating Biomarker Status and Outlook by Region
3.1 Global Circulating Biomarker Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Circulating Biomarker Historic Market Size by Region
3.2.1 Global Circulating Biomarker Sales in Volume by Region (2018-2023)
3.2.2 Global Circulating Biomarker Sales in Value by Region (2018-2023)
3.2.3 Global Circulating Biomarker Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Circulating Biomarker Forecasted Market Size by Region
3.3.1 Global Circulating Biomarker Sales in Volume by Region (2024-2029)
3.3.2 Global Circulating Biomarker Sales in Value by Region (2024-2029)
3.3.3 Global Circulating Biomarker Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Circulating Biomarker by Application
4.1 Circulating Biomarker Market Segment by Application
4.1.1 Hospital
4.1.2 Medical Research Center
4.1.3 Others
4.2 Global Circulating Biomarker Market Size by Application
4.2.1 Global Circulating Biomarker Market Size Overview by Application (2018-2029)
4.2.2 Global Circulating Biomarker Historic Market Size Review by Application (2018-2023)
4.2.3 Global Circulating Biomarker Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Circulating Biomarker Sales Breakdown by Application (2018-2023)
4.3.2 Europe Circulating Biomarker Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Circulating Biomarker Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Circulating Biomarker Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Circulating Biomarker Sales Breakdown by Application (2018-2023)
5 North America Circulating Biomarker by Country
5.1 North America Circulating Biomarker Historic Market Size by Country
5.1.1 North America Circulating Biomarker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Circulating Biomarker Sales in Volume by Country (2018-2023)
5.1.3 North America Circulating Biomarker Sales in Value by Country (2018-2023)
5.2 North America Circulating Biomarker Forecasted Market Size by Country
5.2.1 North America Circulating Biomarker Sales in Volume by Country (2024-2029)
5.2.2 North America Circulating Biomarker Sales in Value by Country (2024-2029)
6 Europe Circulating Biomarker by Country
6.1 Europe Circulating Biomarker Historic Market Size by Country
6.1.1 Europe Circulating Biomarker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Circulating Biomarker Sales in Volume by Country (2018-2023)
6.1.3 Europe Circulating Biomarker Sales in Value by Country (2018-2023)
6.2 Europe Circulating Biomarker Forecasted Market Size by Country
6.2.1 Europe Circulating Biomarker Sales in Volume by Country (2024-2029)
6.2.2 Europe Circulating Biomarker Sales in Value by Country (2024-2029)
7 Asia-Pacific Circulating Biomarker by Region
7.1 Asia-Pacific Circulating Biomarker Historic Market Size by Region
7.1.1 Asia-Pacific Circulating Biomarker Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Circulating Biomarker Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Circulating Biomarker Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Circulating Biomarker Forecasted Market Size by Region
7.2.1 Asia-Pacific Circulating Biomarker Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Circulating Biomarker Sales in Value by Region (2024-2029)
8 Latin America Circulating Biomarker by Country
8.1 Latin America Circulating Biomarker Historic Market Size by Country
8.1.1 Latin America Circulating Biomarker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Circulating Biomarker Sales in Volume by Country (2018-2023)
8.1.3 Latin America Circulating Biomarker Sales in Value by Country (2018-2023)
8.2 Latin America Circulating Biomarker Forecasted Market Size by Country
8.2.1 Latin America Circulating Biomarker Sales in Volume by Country (2024-2029)
8.2.2 Latin America Circulating Biomarker Sales in Value by Country (2024-2029)
9 Middle East and Africa Circulating Biomarker by Country
9.1 Middle East and Africa Circulating Biomarker Historic Market Size by Country
9.1.1 Middle East and Africa Circulating Biomarker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Circulating Biomarker Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Circulating Biomarker Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Circulating Biomarker Forecasted Market Size by Country
9.2.1 Middle East and Africa Circulating Biomarker Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Circulating Biomarker Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Circulating Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Laboratories Circulating Biomarker Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Becton, Dickinson and Company
10.2.1 Becton, Dickinson and Company Company Information
10.2.2 Becton, Dickinson and Company Introduction and Business Overview
10.2.3 Becton, Dickinson and Company Circulating Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Becton, Dickinson and Company Circulating Biomarker Products Offered
10.2.5 Becton, Dickinson and Company Recent Development
10.3 GE Healthcare
10.3.1 GE Healthcare Company Information
10.3.2 GE Healthcare Introduction and Business Overview
10.3.3 GE Healthcare Circulating Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GE Healthcare Circulating Biomarker Products Offered
10.3.5 GE Healthcare Recent Development
10.4 Epigenomics AG
10.4.1 Epigenomics AG Company Information
10.4.2 Epigenomics AG Introduction and Business Overview
10.4.3 Epigenomics AG Circulating Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Epigenomics AG Circulating Biomarker Products Offered
10.4.5 Epigenomics AG Recent Development
10.5 Agilent Technologies
10.5.1 Agilent Technologies Company Information
10.5.2 Agilent Technologies Introduction and Business Overview
10.5.3 Agilent Technologies Circulating Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Agilent Technologies Circulating Biomarker Products Offered
10.5.5 Agilent Technologies Recent Development
10.6 Biocept
10.6.1 Biocept Company Information
10.6.2 Biocept Introduction and Business Overview
10.6.3 Biocept Circulating Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Biocept Circulating Biomarker Products Offered
10.6.5 Biocept Recent Development
10.7 Affymetrix
10.7.1 Affymetrix Company Information
10.7.2 Affymetrix Introduction and Business Overview
10.7.3 Affymetrix Circulating Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Affymetrix Circulating Biomarker Products Offered
10.7.5 Affymetrix Recent Development
10.8 Fluxion Biosciences
10.8.1 Fluxion Biosciences Company Information
10.8.2 Fluxion Biosciences Introduction and Business Overview
10.8.3 Fluxion Biosciences Circulating Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Fluxion Biosciences Circulating Biomarker Products Offered
10.8.5 Fluxion Biosciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Circulating Biomarker Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Circulating Biomarker Industrial Chain Analysis
11.4 Circulating Biomarker Market Dynamics
11.4.1 Circulating Biomarker Industry Trends
11.4.2 Circulating Biomarker Market Drivers
11.4.3 Circulating Biomarker Market Challenges
11.4.4 Circulating Biomarker Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Circulating Biomarker Distributors
12.3 Circulating Biomarker Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
